Senior insider sale
Chief Scientific Officer at BIOXCEL THERAPEUTICS, INC. — senior position signals high conviction
$7.4K
6.84K shares
What this filing means
YOCCA FRANK plans to sell 6.84K shares of BIOXCEL THERAPEUTICS, INC. valued at approximately $7.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/20/2026ACC: 0001964306-26-000253
Officer· Chief Scientific Officer
Since Nov 2018
6.84K
Shares to sell
$7.4K
Approx. market value
6.84K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit awards
Granted as part of issuer equity compensation plan
5/4/2026
6.84KTotal acquired6.84K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2026 | Vesting of restricted stock unit awards Granted as part of issuer equity compensation plan | 6.84K | — |
| Total | 6.84K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
6.84K
Market value
$7.4K
5/20/2026
Total
Units
6.84K
Value
$7.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/20/2026 | 6.84K | $7.4K | NASDAQ | Planned |
| Total | 6.84K | $7.4K | ||